Loading data for DCTH — first visit, this takes a few seconds.

알림

Delcath Systems Inc. (DCTH)

NasdaqCM: DCTH · 실시간 가격 · USD

17.09

+0.34 (2.03%)

종가 기준: Aug 26, 2026, 8:00 PM

16.72

+1.95%

애프터마켓: 7:30 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

2.03% (1D)

데이터 없음

매수호가	12.21
시가총액	569.06M
매출 (ttm)	95.42M
순이익 (ttm)	532K
	0.52
	0.01
	1640
	364.44
P/B (ttm)	4.69
P/S (ttm)	5.96
실적 발표일	Nov 3, 2026

매도호가	21.61
거래량	228,954
평균 거래량 (20일)	572,596
시가	16.90
전일 종가	16.75
일중 범위	16.80 - 17.12
52주 범위	8.12 - 17.42
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

DCTH 소개

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial fo...

[더 보기]

산업 Medical Devices

섹터 Healthcare

IPO 일자 May 3, 2018

직원 수 156

상장 거래소 NasdaqCM

티커 DCTH

웹사이트 https://www.delcath.com

전체 기업 정보

재무 실적

2025년 Delcath Systems의 매출은 85.23M로, 전년 37.2M 대비 129.08% 증가했습니다. 순이익은 2.7M로, -110.23% 감소했습니다.

재무제표

어닝 서프라이즈

Delcath Systems가 Aug 6, 2026에 분기 실적을 발표했습니다:

매출 $29.13M 예상치 하회 $0, 및 20.60% 전년 대비 성장.
EPS 0.07 예상치 상회 0.16, 및 0.00% 전년 대비 성장.

다음 실적 발표

Delcath Systems Inc.의 실적 발표 예정일은 Nov 3, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

2주 전 · Zacks

Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our "Recent...

2주 전 · Zacks

Here's Why Delcath Systems, Inc. (DCTH) is a Great Momentum Stock to Buy

Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.

2주 전 · Zacks

Does Delcath Systems (DCTH) Have the Potential to Rally 42.77% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, th...

3주 전 · Stocktwits

These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 Months

Delcath Systems announced a return to profitability after posting losses in the past two quarters, while Praxis’ second-quarter loss came in narrower than Wall Street had expected

3주 전 · MarketBeat

Delcath Systems Q2 Earnings Call Highlights

Delcath Systems (NASDAQ:DCTH) reported second-quarter 2026 revenue of $29.1 million, up from $24.2 million a year earlier, as growth in HEPZATO KIT sales supported continued commercial expansion and i...

2 페이지 중 1

Delcath Systems Inc. (DCTH)